| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | Chief Executive Officer
2 companies
Duncan Gregory Scott is a Chief Executive Officer at DWTX, with reported holdings spanning 2 companies. Recent filings cover 5 purchases and 0 sales. Those positions are worth an estimated $413K at current prices.
Our model assigns Duncan Gregory Scott a below-average insider score of 32/100, based on 5 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -60.4%.
Duncan Gregory Scott's largest disclosed position is in CRMD as Director, worth about $289K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 25,000 | $1.25 | $31,245.00 | +77.0% | -38.8% | -84.2% | |
| May 23, 2022 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 7,500 | $4.52 | $33,900.00 | +30.0% | +45.5% | -72.3% | |
| Dec 21, 2021 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 5,000 | $5.52 | $27,615.00 | +25.0% | -2.1% | -95.8% | |
| Apr 6, 2021 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 382 | $6.36 | $2,428.60 | +2.0% | +5.0% | -24.4% | |
| Apr 5, 2021 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 15,675 | $6.17 | $96,757.07 | +401.5% | +1.0% | -25.5% |